CDP Venture Capital

CDP Venture Capital, established in 2015 and based in Rome, Italy, is a prominent venture capital investment firm dedicated to fostering innovation and economic development within the country. The firm aims to enhance the venture capital ecosystem by investing in startups and growth companies across a diverse range of sectors, including consumer products, energy, healthcare, information technology, automotive, fashion, food, fintech, insur-tech, advanced manufacturing, agriculture materials, education, big data, life sciences, financial services, software-as-a-service, virtual reality, artificial intelligence, and machine learning. By prioritizing these industries, CDP Venture Capital seeks to create sustainable growth and support the overall development of Italy's entrepreneurial landscape.

Alessandro Angeletti

Investment Manager

Hagaj Badash

Investment Manager

Cristina Bini

Senior Partner

Filippo Bosco Ph.D

Partner

Simona Corno

Senior Partner

Lorenzo Franchini

Senior Partner - Co-Head of the Evolution Fund

Daniele Genovesi

Senior Partner and Fund Manager

francesco grassi

Investment Manager

Elisa Grasso

Senior Investment Manager

Federico Lanciano

Partner

Niccolò Mussi

Investment Manager

Davide Opromolla

Senior Investment Manager

Claudia Pingue

Senior Partner

Matteo Pozzi

Partner, Head of InfraTech Portfolio

Ersilia Rendola

Partner

Davide Santi

Senior Investment Manager

Mario Scuderi

Partner

Giacomo Valentini

Senior Partner

Alessandro Vasconi

Associate

Rita Verderosa

Partner

Rebecca d'aloja

Senior Associate

Past deals in Geneve

EBAMed

Series A in 2025
EBAMed SA is a Swiss startup based in Geneva, established in 2018, that focuses on developing innovative medical technology for treating heart arrhythmias. The company is working on an ultrasound-based device designed to monitor heart motion and facilitate non-invasive ablation therapy using proton beams. This technology aims to provide a safe and effective alternative for patients by allowing real-time synchronization of proton therapy with heart movement. By integrating both hardware and software components, EBAMed's device enhances treatment capabilities for existing proton therapy centers, enabling them to offer advanced, non-invasive treatment options for cardiac patients in an outpatient setting.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.